CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹344 Cr |
| Mar2021 | ₹236 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹184 Cr | 29.48 | |
| Mar2024 | ₹142 Cr | -25.90 | |
| Mar2023 | ₹192 Cr | -44.27 | |
| Mar2022 | ₹344 Cr | 45.91 | |
| Mar2021 | ₹236 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹10,607.0 Cr | -7.2% | -5.9% | -38% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -7.2% |
-5.9% |
-38% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses